A tailored course, built for your situation
Implementation-Focused AI in Pharmaceutical R&D Operations for Audit Teams
A 12-module implementation playbook for audit and compliance leaders navigating AI integration in drug development
The situation this course is for
Pharmaceutical audit functions are increasingly asked to review AI-augmented clinical trial design, compound selection, and safety prediction models. Traditional audit frameworks don't address the speed, complexity, or opacity of machine learning systems. Without an implementation-grade approach, audit teams risk being sidelined in high-impact decisions or issuing qualifications based on incomplete visibility.
Who this is for
Compliance officers, internal auditors, and quality assurance leaders in biopharma organizations who engage with R&D teams using AI for drug discovery, clinical development, or regulatory submissions.
Who this is not for
This is not for data scientists building models, AI researchers, or executives seeking high-level strategy only. It is designed for practitioners who must implement, assess, or govern AI use in real-world R&D workflows.
What you walk away with
- Apply a repeatable framework to audit AI-enhanced R&D processes
- Map model development lifecycles to GxP and 21 CFR Part 11 requirements
- Evaluate data provenance, versioning, and drift in AI training pipelines
- Integrate AI validation checkpoints into existing audit programs
- Produce defensible audit opinions on AI-influenced development decisions
The 12 modules (with all 144 chapters)
- Overview of AI in pharma innovation
- Key terminology for audit professionals
- Regulated vs. experimental AI use cases
- AI adoption trends in top biopharma firms
- Distinguishing automation from intelligence
- Common development environments and tools
- Types of models used in R&D
- Data sources and integration points
- Speed vs. compliance trade-offs
- AI governance maturity models
- Regulatory expectations for transparency
- Audit’s role in AI oversight
- AI and 21 CFR Part 11 compliance
- EMA guidance on algorithmic transparency
- ICH Q9 and risk-based AI evaluation
- GxP implications for model workflows
- Audit trail requirements for AI systems
- Validation expectations for adaptive models
- Labeling AI-influenced submissions
- Inspection readiness for AI projects
- Global regulatory alignment trends
- Emerging standards from ISO and IEEE
- Data integrity in machine learning
- Compliance by design principles
- Phases of the AI development lifecycle
- Project initiation and scoping reviews
- Data acquisition and curation audits
- Feature engineering documentation
- Model selection criteria evaluation
- Training environment controls
- Validation dataset independence
- Hyperparameter tracking
- Version control for models and code
- Change management for model updates
- Retraining triggers and approvals
- Decommissioning AI models
- Data lineage mapping techniques
- Source system validation
- Data transformation audit trails
- Handling missing or imputed data
- Bias detection in training sets
- Data versioning practices
- Audit logs for data pipelines
- Access controls for sensitive datasets
- Data retention and deletion policies
- Cross-border data transfer compliance
- Anonymization and de-identification
- Data quality scorecards
- Validation vs. verification distinctions
- Pre-specifying performance metrics
- Testing for overfitting and drift
- Cross-validation audit strategies
- Stress testing model assumptions
- Evaluating interpretability methods
- Benchmarking against baselines
- Sensitivity analysis techniques
- Reproducibility of results
- Third-party model validation
- Documentation completeness checks
- Peer review integration
- Importance of explainability in regulated settings
- Model-agnostic interpretation tools
- Local vs. global explanations
- SHAP and LIME for audit use
- Surrogate modeling techniques
- Visualizing decision pathways
- Assessing explanation reliability
- Handling black-box models
- Documentation of interpretability steps
- Stakeholder communication of insights
- Limits of current explainability
- Audit trail for interpretation
- Defining model change triggers
- Change control board roles
- Impact assessment for model updates
- Rollback procedures and testing
- Monitoring for data drift
- Performance degradation thresholds
- Alerting and escalation protocols
- Automated logging of model behavior
- Periodic revalidation schedules
- Version comparison techniques
- User feedback integration
- Incident response for AI failures
- AI for adaptive trial designs
- Patient matching algorithm audits
- Predictive enrollment modeling
- Site performance forecasting
- Bias in digital recruitment tools
- Endpoint prediction models
- Real-world data integration
- Informed consent implications
- Monitoring AI-assisted visits
- Data safety monitoring boards
- Regulatory submission of AI methods
- Audit trails for dynamic protocols
- AI in target validation
- Virtual screening workflows
- Generative chemistry models
- Predicting ADMET properties
- Toxicity risk modeling
- Data sources for chemical libraries
- Validation of in silico results
- Integration with wet-lab testing
- IP and publication implications
- Reproducibility of discovery models
- Audit of collaboration platforms
- Model handoff to development
- AI inputs to CAPA investigations
- Deviation tracking for model errors
- Change control integration
- Training records for AI users
- Document management for models
- Electronic signatures and approvals
- Audit management system updates
- Supplier oversight for AI vendors
- Quality risk assessments for AI
- Periodic review of AI systems
- Management review reporting
- Continuous improvement feedback
- Due diligence for AI vendors
- Contractual requirements for transparency
- Audit rights and access
- Cloud infrastructure compliance
- Shared responsibility models
- Data ownership and portability
- Service level agreements for AI
- Incident reporting obligations
- Subcontractor oversight
- Security and access logs
- Performance validation upon delivery
- Exit strategy and model transfer
- Assessing organizational AI maturity
- Staffing and skill development
- Developing AI audit checklists
- Risk-based audit planning
- Coordination with data governance
- Engaging with R&D leaders
- Reporting to quality and compliance
- Training auditors on AI concepts
- Metrics for audit effectiveness
- Continuous learning mechanisms
- Scaling the audit function
- Future-proofing for new AI forms
How this maps to your situation
- Auditing AI in early-phase drug discovery
- Validating AI-enhanced clinical trial protocols
- Assessing vendor-built models for regulatory submission
- Integrating AI oversight into annual quality reviews
Before vs. after
What's included with your purchase
- 12 modules with 12 chapters each (144 chapters)
- Downloadable templates and worked examples for every module
- Hand-built implementation playbook delivered alongside course access
- 30-day money-back guarantee
Delivery and format
- Course and learning environment access provisioned within 24 hours of purchase
- Hand-built implementation playbook delivered alongside course access
Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.
Time investment: Approximately 45, 60 minutes per module, designed for completion over 8, 12 weeks with flexible pacing.
How this compares to the alternatives
Unlike academic courses focused on theory or technical AI training, this program is tailored specifically for audit and compliance professionals who must implement practical oversight, not build models. It bridges regulatory expectations with real-world operational constraints.
Frequently asked
Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.